Donaldson M S
Institute of Medicine, Washington, DC, USA.
Jt Comm J Qual Improv. 1998 Dec;24(12):711-25. doi: 10.1016/s1070-3241(16)30417-5.
It is often difficult to understand where responsibility lies for monitoring and improving quality in managed care. From 1996 through 1998 a group of individuals convened by the Institute of Medicine's (Washington, DC) National Roundtable on Health Care Quality developed a model of accountability for the quality of care provided by managed care organizations (MCOs). Each of three overarching forms of accountability (professional, market, and regulatory) has a set of tools for imposing accountability and-because accountability relationships are not self-enforcing-sanctions for failures of accountability.
Fiduciary relationships in medicine are an essential part of any quality accountability mechanism, and it will be important to maintain the strength of the professional model in the changing health care system. Yet it is not easy to preserve the strength of the professional model in an MCO environment in which professionals are not dominant, and there is likely to be increasing pressure to weaken their autonomy.
The primary assumption of market accountability is that consumers will select options based on perceived value to them and will make new choices based on their information and experience. Market accountability requires choice among competing providers and information to inform choice. In health care, however, individuals rarely have the information they need and often do not have choice. Accountability for quality generally has not been a major feature in contracts.
There is a widespread perception of defects in a market-based health care system. Many believe there is a need for a regulatory structure to correct market failures. The use of regulation to impose accountability for quality requires that a regulatory framework, penalties for violations, and effective enforcement mechanisms are all established. PUBLIC GOODS: The model of accountability for quality in managed care does not promote public goods such as education, research, public health, or care for the uninsured. Indeed, the locus of responsibility to the community when markets fail to supply these public goods is controversial. Nevertheless, such responsibility should be considered by MCOs and policy makers.
Given market-driven models of health care financing and delivery, it might be feasible and desirable to encourage collaboration among MCOs to improve quality, whether at the national or local market level. The health professions in general, and the medical profession in particular, are and must be accountable to society for providing leadership in the development of knowledge about effective medical care, in defining high-quality care, and in advocating for and improving the quality of care.
Establishing effective accountability for quality involves multiple entities and many different kinds of accountability relationships. The three forms of accountability interact, and all operate at once.
在管理式医疗中,常常难以明确监测和提高质量的责任归属。1996年至1998年期间,由美国国家医学院(华盛顿特区)医疗保健质量全国圆桌会议召集的一群人,制定了一个关于管理式医疗组织(MCO)所提供医疗服务质量的问责模型。三种总体问责形式(专业、市场和监管)中的每一种都有一套用于实施问责的工具,并且由于问责关系并非自我执行,所以还有针对问责失败的制裁措施。
医学中的信托关系是任何质量问责机制的重要组成部分,在不断变化的医疗保健系统中保持专业模式的优势至关重要。然而,在专业人员不占主导地位且削弱其自主权的压力可能不断增加的MCO环境中,要保持专业模式的优势并非易事。
市场问责的主要假设是,消费者会根据对他们的感知价值来选择选项,并根据他们的信息和经验做出新的选择。市场问责要求在相互竞争的提供者之间进行选择,并提供信息以指导选择。然而,在医疗保健领域,个人很少拥有他们所需的信息,而且往往没有选择的机会。质量问责通常并不是合同中的主要特征。
人们普遍认为基于市场的医疗保健系统存在缺陷。许多人认为需要一个监管结构来纠正市场失灵。利用监管来对质量实施问责,要求建立一个监管框架、违规处罚措施以及有效的执行机制。
管理式医疗中的质量问责模型并不促进教育、研究、公共卫生或为未参保者提供医疗等公共物品。事实上,当市场无法提供这些公共物品时,对社区的责任归属存在争议。尽管如此,MCO和政策制定者应该考虑这种责任。
鉴于医疗保健融资和提供的市场驱动模式,鼓励MCO之间在国家或地方市场层面进行合作以提高质量可能是可行且可取的。总体而言,卫生专业人员,尤其是医学专业人员,有责任且必须对社会负责,在有效医疗保健知识的发展、高质量医疗的定义以及倡导和提高医疗服务质量方面发挥领导作用。
建立有效的质量问责涉及多个实体和许多不同类型的问责关系。这三种问责形式相互作用,并且同时发挥作用。